Olema Pharmaceuticals, Inc. (OLMA)

Olema Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	50.64	139.48	68.54	23.7	13.81	338.55
Short-Term Investments	342.07	294.61	193.27	180.72	273.44	-
Cash & Short-Term Investments	392.71	434.09	261.81	204.42	287.25	338.55
Cash Growth	57.73%	65.80%	28.07%	-28.84%	-15.15%	497766.18%
Other Receivables	1.92	2.12	0.67	0.32	0.13	-
Receivables	1.92	2.12	0.67	0.32	0.13	-
Prepaid Expenses	1.76	1.9	2.35	2.64	2.97	3.01
Other Current Assets	0.28	0.37	1.68	1.52	0.33	0.58
Total Current Assets	396.66	438.47	266.51	208.9	290.69	342.14
Property, Plant & Equipment	1.71	2.06	3.26	2.5	4.72	0.08
Long-Term Deferred Charges	0.74	0.68	-	-	-	-
Other Long-Term Assets	10.53	9.76	7.17	4.25	0.54	0.51
Total Assets	409.64	450.98	276.95	215.65	295.95	342.72
Accounts Payable	0.15	4.46	2.7	0.37	0.02	0.72
Accrued Expenses	24.89	36.09	17.86	15.09	7.81	3.43
Current Portion of Leases	1.03	1.17	0.99	1.02	0.93	-
Current Income Taxes Payable	-	0.04	0.07	0.07	0.09	0.2
Other Current Liabilities	-	-	-	-	0.17	0.24
Total Current Liabilities	26.06	41.76	21.62	16.55	9.02	4.59
Long-Term Leases	0.12	0.26	1.43	1.55	2.36	-
Total Liabilities	26.19	42.02	23.05	18.1	11.38	4.59
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-In Capital	848.52	843.92	559.18	408.33	388.9	371.23
Retained Earnings	-465.5	-435.11	-305.63	-208.98	-104.19	-33.09
Comprehensive Income & Other	0.42	0.14	0.35	-1.81	-0.15	-
Total Common Equity	383.45	408.96	253.9	197.55	284.57	338.14
Shareholders' Equity	383.45	408.96	253.9	197.55	284.57	338.14
Total Liabilities & Equity	409.64	450.98	276.95	215.65	295.95	342.72
Total Debt	1.15	1.43	2.42	2.57	3.29	-
Net Cash (Debt)	391.56	432.66	259.39	201.86	283.96	338.55
Net Cash Growth	58.67%	66.80%	28.50%	-28.91%	-16.12%	497766.18%
Net Cash Per Share	5.91	7.37	5.73	5.05	7.18	48.22
Filing Date Shares Outstanding	68.42	68.33	55.91	40.63	39.85	39.43
Total Common Shares Outstanding	68.33	74.31	54.99	40.29	39.84	39.43
Working Capital	370.6	396.72	244.89	192.35	281.67	337.55
Book Value Per Share	5.61	5.50	4.62	4.90	7.14	8.57
Tangible Book Value	383.45	408.96	253.9	197.55	284.57	338.14
Tangible Book Value Per Share	5.61	5.50	4.62	4.90	7.14	8.57
Machinery	-	-	-	-	1.7	0.14

Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q